市場調查報告書

腎交感神經阻斷術系統市場:全球產業趨勢,佔有率,規模,成長,機會,預測(2020年∼2025年)

Renal Denervation Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

出版商 IMARC Services Private Limited 商品編碼 967702
出版日期 內容資訊 英文 142 Pages
商品交期: 2-3個工作天內
價格
腎交感神經阻斷術系統市場:全球產業趨勢,佔有率,規模,成長,機會,預測(2020年∼2025年) Renal Denervation Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025
出版日期: 2020年10月16日內容資訊: 英文 142 Pages
簡介

全球腎交感神經阻斷術系統的市場規模,從2014年到2019年強力擴大。腎交感神經阻斷術(RDN),是使用腎動脈壁內的交感神經的導管伴隨切除的介入手術。

抽煙和飲酒的人增加,不健康的飲食模式,久坐忙碌的生活習慣,高齡人口的增加等,高血壓等文明病的盛行率大幅度上升,是促進市場成長的重要要素之一。除此之外,與RDN系統相關的優勢(例如恢復速度,安全性,時間效率和成本效益)也成為關鍵的成長動力。可是,由於冠狀病毒(COVID-19)的劇增造成醫院訪問的減少和選擇性醫療治療的日程變更等,妨礙市場成長。如果情形控制住,市場預計成長。今後五年全球腎交感神經阻斷術系統市場預計繼續強力成長。

本報告提供腎交感神經阻斷術系統市場相關調查,市場概要,以及各產品類型,各產品,各科技,各用途,各終端用戶,各地區的趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 序文

第2章 範圍與調查手法

第3章 摘要整理

第4章 簡介

第5章 全球腎交感神經阻斷術系統市場

  • 市場概要
  • 市場效能
  • COVID-19的影響

第6章 各產品類型市場明細

  • 導管
    • 主要的種類
  • RF發電機
  • Neuromodulation劑

第7章 各產品市場明細

  • Symplicity
  • Vessix(V2)
  • EnligHTN
  • Paradise
  • Iberis
  • 其他

第8章 各科技市場明細

  • 超音波切除
  • 射頻消融術
  • Micro-Infusion

第9章 各用途市場明細

  • 高血壓
  • 心臟障礙
  • 糖尿病
  • 腎功能衰竭
  • 其他

第10章 各終端用戶市場明細

  • 診斷中心和醫院
  • 門診病人診療中心
  • 其他

第11章 各地區市場明細

  • 北美
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 南美
    • 巴西
    • 墨西哥
    • 其他
  • 中東、非洲
    • 各國市場明細

第12章 SWOT分析

第13章 價值鏈分析

第14章 波特五力分析

第15章 價格分析

第16章 競爭情形

  • 市場結構
  • 主要參與者
  • 主要參與者的簡介
    • Boston Scientific Group
    • Kona Medical Inc.
    • Medtronic Plc
    • Mercator MedSystems
    • ReCor Medical Inc. (Otsuka Holdings Co. Ltd.)
    • Renal Dynamics
    • St. Jude Medical Inc. (Abbott)
    • Terumo Corporation
目錄
Product Code: SR1019N43_Report

The global renal denervation systems market experienced robust growth during 2014-2019. Renal denervation (RDN) is an interventional procedure that involves a catheter-based ablation of the sympathetic nerves within the renal artery wall. It maximizes nerve disruption, lowers renin secretion, stimulates natriuresis, and improves renal hemodynamics or blood flow. As a result, RDN systems are extensively used to treat refractory hypertension cases wherein optimal therapy cannot provide relief to the patients.

A significant rise in the prevalence of lifestyle diseases, such as hypertension, on account of the increasing number of individuals who smoke and consume alcohol, rising unhealthy dietary patterns, sedentary and hectic lifestyles, and the growing geriatric population represents, one of the key factors strengthening market growth. Apart from this, the advantages associated with the RDN system, such as fast recovery, safety, time efficiency and cost-effectiveness, are acting as another major growth-inducing factor. Furthermore, the escalating demand for minimally invasive (MI) surgery is also contributing to the growth of the market. Other factors, including the introduction of micro-infusion technology, improving healthcare infrastructure, increasing research and development (R&D) activities and the rising number of filings for regulatory approvals of the systems, are creating a positive influence on the market growth. However, a decline in the hospital visits and rescheduling of elective health procedures due to the surging cases of the coronavirus disease (COVID-19) are hampering the market growth. The market is anticipated to grow once the situation is under control. Looking forward, IMARC Group expects the global renal denervation systems market to continue its strong growth during the next five years.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global renal denervation systems market report, along with forecasts for growth at the global, regional and country level from 2020-2025. Our report has categorized the market based on region, product type, product, technology, application and end user.

Breakup by Product Type:

  • Copper-Based
  • Single Electrode Catheter
  • Multi Electrode Catheter
  • RF Generator
  • Nerve Modifying Agents

Breakup by Product:

  • Symplicity
  • Vessix (V2)
  • EnligHTN
  • Paradise
  • Iberis
  • Others

Breakup by Technology:

  • Ultrasound Ablation
  • Radiofrequency Ablation
  • Microinfusion

Breakup by Application:

  • Hypertension
  • Cardiac Disorders
  • Diabetes
  • Renal Failure
  • Others

Breakup by End User:

  • Diagnostic Centers and Hospitals
  • Ambulatory Care Centers
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The report has also analysed the competitive landscape of the market with some of the key players being Boston Scientific Group, Kona Medical Inc., Medtronic Plc, Mercator MedSystems, ReCor Medical Inc. (Otsuka Holdings Co. Ltd.), Renal Dynamics, St. Jude Medical Inc. (Abbott) and Terumo Corporation.

Key Questions Answered in This Report:

  • How has the global renal denervation systems market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global renal denervation systems market?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global renal denervation systems market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Renal Denervation Systems Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Catheters
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Single Electrode Catheter
      • 6.1.2.2 Multi Electrode Catheter
    • 6.1.3 Market Forecast
  • 6.2 RF Generator
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Nerve Modifying Agents
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Symplicity
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Vessix (V2)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 EnligHTN
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Paradise
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Iberis
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Ultrasound Ablation
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Radiofrequency Ablation
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Microinfusion
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Hypertension
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Cardiac Disorders
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Diabetes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Renal Failure
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by End-User

  • 10.1 Diagnostic Centers and Hospitals
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Ambulatory Care Centers
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Boston Scientific Group
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Kona Medical Inc.
      • 16.3.2.1 Company Overview .
      • 16.3.2.2 Product Portfolio
    • 16.3.3 Medtronic Plc
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 Mercator MedSystems
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 ReCor Medical Inc. (Otsuka Holdings Co. Ltd.)
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 Renal Dynamics
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 St. Jude Medical Inc. (Abbott)
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 Terumo Corporation
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Renal Denervation Systems Market: Major Drivers and Challenges
  • Figure 2: Global: Renal Denervation Systems Market: Sales Value (in Billion US$), 2014-2019
  • Figure 3: Global: Renal Denervation Systems Market: Breakup by Product Type (in %), 2019
  • Figure 4: Global: Renal Denervation Systems Market: Breakup by Product (in %), 2019
  • Figure 5: Global: Renal Denervation Systems Market: Breakup by Technology (in %), 2019
  • Figure 6: Global: Renal Denervation Systems Market: Breakup by Application (in %), 2019
  • Figure 7: Global: Renal Denervation Systems Market: Breakup by End-User (in %), 2019
  • Figure 8: Global: Renal Denervation Systems Market: Breakup by Region (in %), 2019
  • Figure 9: Global: Renal Denervation Systems Market Forecast: Sales Value (in Billion US$), 2020-2025
  • Figure 10: Global: Renal Denervation Systems (Catheters) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 11: Global: Renal Denervation Systems (Catheters) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 12: Global: Renal Denervation Systems (RF Generator) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 13: Global: Renal Denervation Systems (RF Generator) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 14: Global: Renal Denervation Systems (Nerve Modifying Agents) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 15: Global: Renal Denervation Systems (Nerve Modifying Agents) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 16: Global: Renal Denervation Systems (Symplicity) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 17: Global: Renal Denervation Systems (Symplicity) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 18: Global: Renal Denervation Systems (Vessix- V2) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 19: Global: Renal Denervation Systems (Vessix- V2) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 20: Global: Renal Denervation Systems (EnligHTN) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 21: Global: Renal Denervation Systems (EnligHTN) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 22: Global: Renal Denervation Systems (Paradise) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 23: Global: Renal Denervation Systems (Paradise) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 24: Global: Renal Denervation Systems (Iberis) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 25: Global: Renal Denervation Systems (Iberis) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 26: Global: Renal Denervation Systems (Other Product Types) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 27: Global: Renal Denervation Systems (Other Product Types) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 28: Global: Renal Denervation Systems (Ultrasound Ablation) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 29: Global: Renal Denervation Systems (Ultrasound Ablation) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 30: Global: Renal Denervation Systems (Radiofrequency Ablation) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 31: Global: Renal Denervation Systems (Radiofrequency Ablation) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 32: Global: Renal Denervation Systems (Microinfusion) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 33: Global: Renal Denervation Systems (Microinfusion) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 34: Global: Renal Denervation Systems (Hypertension) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 35: Global: Renal Denervation Systems (Hypertension) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 36: Global: Renal Denervation Systems (Cardiac Disorders) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 37: Global: Renal Denervation Systems (Cardiac Disorders) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 38: Global: Renal Denervation Systems (Diabetes) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 39: Global: Renal Denervation Systems (Diabetes) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 40: Global: Renal Denervation Systems (Renal Failure) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 41: Global: Renal Denervation Systems (Renal Failure) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 42: Global: Renal Denervation Systems (Other Applications) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 43: Global: Renal Denervation Systems (Other Applications) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 44: Global: Renal Denervation Systems (Diagnostic Centers and Hospitals) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 45: Global: Renal Denervation Systems (Diagnostic Centers and Hospitals) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 46: Global: Renal Denervation Systems (Ambulatory Care Centers) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 47: Global: Renal Denervation Systems (Ambulatory Care Centers) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 48: Global: Renal Denervation Systems (Other End Users) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 49: Global: Renal Denervation Systems (Other End Users) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 50: North America: Renal Denervation Systems Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 51: North America: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 52: United States: Renal Denervation Systems Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 53: United States: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 54: Canada: Renal Denervation Systems Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 55: Canada: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 56: Asia Pacific: Renal Denervation Systems Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 57: Asia Pacific: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 58: China: Renal Denervation Systems Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 59: China: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2020-2024
  • Figure 60: Japan: Renal Denervation Systems Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 61: Japan: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2020-2024
  • Figure 62: India: Renal Denervation Systems Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 63: India: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2020-2024
  • Figure 64: South Korea: Renal Denervation Systems Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 65: South Korea: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2020-2024
  • Figure 66: Australia: Renal Denervation Systems Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 67: Australia: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 68: Indonesia: Renal Denervation Systems Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 69: Indonesia: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 70: Others: Renal Denervation Systems Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 71: Others: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 72: Europe: Renal Denervation Systems Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 73: Europe: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 74: Germany: Renal Denervation Systems Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 75: Germany: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 76: France: Renal Denervation Systems Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 77: France: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 78: United Kingdom: Renal Denervation Systems Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 79: United Kingdom: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 80: Italy: Renal Denervation Systems Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 81: Italy: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 82: Spain: Renal Denervation Systems Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 83: Spain: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 84: Russia: Renal Denervation Systems Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 85: Russia: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 86: Others: Renal Denervation Systems Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 87: Others: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 88: Latin America: Renal Denervation Systems Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 89: Latin America: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 90: Brazil: Renal Denervation Systems Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 91: Brazil: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 92: Mexico: Renal Denervation Systems Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 93: Mexico: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 94: Others: Renal Denervation Systems Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 95: Others: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 96: Middle East and Africa: Renal Denervation Systems Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 97: Middle East and Africa: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 98: Global: Renal Denervation Systems Industry: SWOT Analysis
  • Figure 99: Global: Renal Denervation Systems Industry: Value Chain Analysis
  • Figure 100: Global: Renal Denervation Systems Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Renal Denervation Systems Market: Key Industry Highlights, 2019 and 2025
  • Table 2: Global: Renal Denervation Systems Market Forecast: Breakup by Product Type (in Million US$), 2020-2025
  • Table 3: Global: Renal Denervation Systems Market Forecast: Breakup by Product (in Million US$), 2020-2025
  • Table 4: Global: Renal Denervation Systems Market Forecast: Breakup by Technology (in Million US$), 2020-2025
  • Table 5: Global: Renal Denervation Systems Market Forecast: Breakup by Application (in Million US$), 2020-2025
  • Table 6: Global: Renal Denervation Systems Market Forecast: Breakup by End-User (in Million US$), 2020-2025
  • Table 7: Global: Renal Denervation Systems Market Forecast: Breakup by Region (in Million US$), 2020-2025
  • Table 8: Global: Renal Denervation Systems Market Structure
  • Table 9: Global: Renal Denervation Systems Market: Key Players